This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and…

A second-generation antipsychotic designed to antagonize both D2 and 5-HT2A receptors with little effect on cholinergic and β-adrenergic receptors; affects α2-adrenergic and histamine H1 receptors.